Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Adrenergic signaling in cardiomyocytes
|
Bupivacaine hydrochloride Bupivacaine hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Adrenergic signaling in cardiomyocytes
|
Bupivacaine Bupivacaine 💬Adrenergic signaling in cardiomyocytes
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Adrenergic signaling in cardiomyocytes
|
Ropivacaine hydrochloride Ropivacaine hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬3. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Adrenergic signaling in cardiomyocytes
|
Ropivacaine Ropivacaine 💬Adrenergic signaling in cardiomyocytes
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬3. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PTGS2 [1] PTGS2 💬Alzheimer disease
|
Valdecoxib Valdecoxib 💬Alzheimer disease
| Parecoxib | 046 [3] 46, 71, 271 💬5. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PTGS2 [1] PTGS2 💬Alzheimer disease
|
Parecoxib Parecoxib 💬Alzheimer disease
| Parecoxib | 046 [3] 46, 71, 271 💬5. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PTGS2 [1] PTGS2 💬Alzheimer disease
|
Parecoxib sodium Parecoxib sodium 💬Alzheimer disease
| Parecoxib | 046 [3] 46, 71, 271 💬5. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pitavastatin calcium Pitavastatin calcium 💬AMPK signaling pathway
| Pitavastatin | 049 [4] 49, 71, 79, 90 💬8. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pitavastatin magnesium Pitavastatin magnesium 💬AMPK signaling pathway
| Pitavastatin | 049 [4] 49, 71, 79, 90 💬8. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Arachidonic acid metabolism 💬 5 genes, 29 drugs (DrugBank) and 46 diseases |
PTGS2 [1] PTGS2 💬Arachidonic acid metabolism
|
Valdecoxib Valdecoxib 💬Arachidonic acid metabolism
| Parecoxib | 046 [3] 46, 71, 271 💬10. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Arachidonic acid metabolism 💬 5 genes, 29 drugs (DrugBank) and 46 diseases |
PTGS2 [1] PTGS2 💬Arachidonic acid metabolism
|
Parecoxib Parecoxib 💬Arachidonic acid metabolism
| Parecoxib | 046 [3] 46, 71, 271 💬10. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Arachidonic acid metabolism 💬 5 genes, 29 drugs (DrugBank) and 46 diseases |
PTGS2 [1] PTGS2 💬Arachidonic acid metabolism
|
Parecoxib sodium Parecoxib sodium 💬Arachidonic acid metabolism
| Parecoxib | 046 [3] 46, 71, 271 💬10. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pitavastatin calcium Pitavastatin calcium 💬Bile secretion
| Pitavastatin | 049 [4] 49, 71, 79, 90 💬13. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pitavastatin magnesium Pitavastatin magnesium 💬Bile secretion
| Pitavastatin | 049 [4] 49, 71, 79, 90 💬13. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PTGS2 [1] PTGS2 💬C-type lectin receptor signaling pathway
|
Valdecoxib Valdecoxib 💬C-type lectin receptor signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬15. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PTGS2 [1] PTGS2 💬C-type lectin receptor signaling pathway
|
Parecoxib Parecoxib 💬C-type lectin receptor signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬15. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PTGS2 [1] PTGS2 💬C-type lectin receptor signaling pathway
|
Parecoxib sodium Parecoxib sodium 💬C-type lectin receptor signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬15. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Cadherin signaling
|
Bupivacaine hydrochloride Bupivacaine hydrochloride 💬Cadherin signaling
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬18. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Cadherin signaling
|
Bupivacaine Bupivacaine 💬Cadherin signaling
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬18. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Cadherin signaling
|
Ropivacaine hydrochloride Ropivacaine hydrochloride 💬Cadherin signaling
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬20. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
SCN5A [1] SCN5A 💬Cadherin signaling
|
Ropivacaine Ropivacaine 💬Cadherin signaling
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬20. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Chemical carcinogenesis - DNA adducts 💬 1 gene, 26 drugs (DrugBank) and 43 diseases |
PTGS2 [1] PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Valdecoxib Valdecoxib 💬Chemical carcinogenesis - DNA adducts
| Parecoxib | 046 [3] 46, 71, 271 💬22. Chemical carcinogenesis - DNA adducts
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Chemical carcinogenesis - DNA adducts 💬 1 gene, 26 drugs (DrugBank) and 43 diseases |
PTGS2 [1] PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Parecoxib Parecoxib 💬Chemical carcinogenesis - DNA adducts
| Parecoxib | 046 [3] 46, 71, 271 💬22. Chemical carcinogenesis - DNA adducts
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Chemical carcinogenesis - DNA adducts 💬 1 gene, 26 drugs (DrugBank) and 43 diseases |
PTGS2 [1] PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Parecoxib sodium Parecoxib sodium 💬Chemical carcinogenesis - DNA adducts
| Parecoxib | 046 [3] 46, 71, 271 💬22. Chemical carcinogenesis - DNA adducts
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Collecting duct acid secretion 💬 3 genes, 10 drugs (DrugBank) and 36 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬Collecting duct acid secretion
| Lansoprazole | 063 [8] 63, 71, 85, 98, 166, 222, 223, 299 💬25. Collecting duct acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Edoxaban tosilate hydrate Edoxaban tosilate hydrate 💬Complement and coagulation cascades
| Edoxaban | 046 [4] 46, 71, 88, 222 💬26. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Edoxaban Edoxaban 💬Complement and coagulation cascades
| Edoxaban | 046 [4] 46, 71, 88, 222 💬26. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Edoxaban tosylate Edoxaban tosylate 💬Complement and coagulation cascades
| Edoxaban | 046 [4] 46, 71, 88, 222 💬26. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
SERPINC1 [1] SERPINC1 💬Complement and coagulation cascades
|
Enoxaparin sodium Enoxaparin sodium 💬Complement and coagulation cascades
| Enoxaparin | 046 [6] 46, 48, 71, 222, 223, 327 💬29. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
SERPINC1 [1] SERPINC1 💬Complement and coagulation cascades
|
Adomiparin Adomiparin 💬Complement and coagulation cascades
| Enoxaparin | 046 [6] 46, 48, 71, 222, 223, 327 💬29. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
SCN1A [1] SCN1A 💬Dopaminergic synapse
|
Bupivacaine hydrochloride Bupivacaine hydrochloride 💬Dopaminergic synapse
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬31. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
SCN1A [1] SCN1A 💬Dopaminergic synapse
|
Bupivacaine Bupivacaine 💬Dopaminergic synapse
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬31. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
SCN1A [1] SCN1A 💬Dopaminergic synapse
|
Ropivacaine hydrochloride Ropivacaine hydrochloride 💬Dopaminergic synapse
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬33. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
SCN1A [1] SCN1A 💬Dopaminergic synapse
|
Ropivacaine Ropivacaine 💬Dopaminergic synapse
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬33. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
P2RY12 [1] P2RY12 💬Efferocytosis
|
Clopidogrel bisulfate Clopidogrel bisulfate 💬Efferocytosis
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬35. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
P2RY12 [1] P2RY12 💬Efferocytosis
|
Clopidogrel Clopidogrel 💬Efferocytosis
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬35. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
P2RY12 [1] P2RY12 💬Efferocytosis
|
Clopidogrel hydrochloride Clopidogrel hydrochloride 💬Efferocytosis
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬35. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
P2RY12 [1] P2RY12 💬Efferocytosis
|
Clopidogrel besilate Clopidogrel besilate 💬Efferocytosis
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬35. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬Efferocytosis
|
Valdecoxib Valdecoxib 💬Efferocytosis
| Parecoxib | 046 [3] 46, 71, 271 💬39. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬Efferocytosis
|
Parecoxib Parecoxib 💬Efferocytosis
| Parecoxib | 046 [3] 46, 71, 271 💬39. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬Efferocytosis
|
Parecoxib sodium Parecoxib sodium 💬Efferocytosis
| Parecoxib | 046 [3] 46, 71, 271 💬39. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Endocrine and other factor-regulated calcium reabsorption 💬 9 genes, 31 drugs (DrugBank) and 50 diseases |
PTH1R [1] PTH1R 💬Endocrine and other factor-regulated calcium reabsorption
|
Teriparatide acetate Teriparatide acetate 💬Endocrine and other factor-regulated calcium reabsorption
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬42. Endocrine and other factor-regulated calcium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Endocrine and other factor-regulated calcium reabsorption 💬 9 genes, 31 drugs (DrugBank) and 50 diseases |
PTH1R [1] PTH1R 💬Endocrine and other factor-regulated calcium reabsorption
|
Teriparatide Teriparatide 💬Endocrine and other factor-regulated calcium reabsorption
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬42. Endocrine and other factor-regulated calcium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Endocrine and other factor-regulated calcium reabsorption 💬 9 genes, 31 drugs (DrugBank) and 50 diseases |
PTH1R [1] PTH1R 💬Endocrine and other factor-regulated calcium reabsorption
|
Teriparatide acetate Teriparatide acetate 💬Endocrine and other factor-regulated calcium reabsorption
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬42. Endocrine and other factor-regulated calcium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Gastric acid secretion 💬 14 genes, 54 drugs (DrugBank) and 63 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬Gastric acid secretion
| Lansoprazole | 063 [8] 63, 71, 85, 98, 166, 222, 223, 299 💬45. Gastric acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
PTH1R [1] PTH1R 💬Hormone signaling
|
Teriparatide acetate Teriparatide acetate 💬Hormone signaling
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬46. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
PTH1R [1] PTH1R 💬Hormone signaling
|
Teriparatide Teriparatide 💬Hormone signaling
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬46. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
PTH1R [1] PTH1R 💬Hormone signaling
|
Teriparatide acetate Teriparatide acetate 💬Hormone signaling
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬46. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PTGS2 [1] PTGS2 💬Human cytomegalovirus infection
|
Valdecoxib Valdecoxib 💬Human cytomegalovirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬49. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PTGS2 [1] PTGS2 💬Human cytomegalovirus infection
|
Parecoxib Parecoxib 💬Human cytomegalovirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬49. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PTGS2 [1] PTGS2 💬Human cytomegalovirus infection
|
Parecoxib sodium Parecoxib sodium 💬Human cytomegalovirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬49. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PTGS2 [1] PTGS2 💬Human papillomavirus infection
|
Valdecoxib Valdecoxib 💬Human papillomavirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬52. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PTGS2 [1] PTGS2 💬Human papillomavirus infection
|
Parecoxib Parecoxib 💬Human papillomavirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬52. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PTGS2 [1] PTGS2 💬Human papillomavirus infection
|
Parecoxib sodium Parecoxib sodium 💬Human papillomavirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬52. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
SCN8A [1] SCN8A 💬IgSF CAM signaling
|
Bupivacaine hydrochloride Bupivacaine hydrochloride 💬IgSF CAM signaling
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬55. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
SCN8A [1] SCN8A 💬IgSF CAM signaling
|
Bupivacaine Bupivacaine 💬IgSF CAM signaling
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬55. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
SCN8A [1] SCN8A 💬IgSF CAM signaling
|
Ropivacaine hydrochloride Ropivacaine hydrochloride 💬IgSF CAM signaling
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬57. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
SCN8A [1] SCN8A 💬IgSF CAM signaling
|
Ropivacaine Ropivacaine 💬IgSF CAM signaling
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬57. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
PTGS2 [1] PTGS2 💬IL-17 signaling pathway
|
Valdecoxib Valdecoxib 💬IL-17 signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬59. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
PTGS2 [1] PTGS2 💬IL-17 signaling pathway
|
Parecoxib Parecoxib 💬IL-17 signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬59. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
PTGS2 [1] PTGS2 💬IL-17 signaling pathway
|
Parecoxib sodium Parecoxib sodium 💬IL-17 signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬59. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PTGS2 [1] PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Valdecoxib Valdecoxib 💬Kaposi sarcoma-associated herpesvirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬62. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PTGS2 [1] PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Parecoxib Parecoxib 💬Kaposi sarcoma-associated herpesvirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬62. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PTGS2 [1] PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Parecoxib sodium Parecoxib sodium 💬Kaposi sarcoma-associated herpesvirus infection
| Parecoxib | 046 [3] 46, 71, 271 💬62. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
PTGS2 [1] PTGS2 💬Leishmaniasis
|
Valdecoxib Valdecoxib 💬Leishmaniasis
| Parecoxib | 046 [3] 46, 71, 271 💬65. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
PTGS2 [1] PTGS2 💬Leishmaniasis
|
Parecoxib Parecoxib 💬Leishmaniasis
| Parecoxib | 046 [3] 46, 71, 271 💬65. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
PTGS2 [1] PTGS2 💬Leishmaniasis
|
Parecoxib sodium Parecoxib sodium 💬Leishmaniasis
| Parecoxib | 046 [3] 46, 71, 271 💬65. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PTGS2 [1] PTGS2 💬MicroRNAs in cancer
|
Valdecoxib Valdecoxib 💬MicroRNAs in cancer
| Parecoxib | 046 [3] 46, 71, 271 💬68. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PTGS2 [1] PTGS2 💬MicroRNAs in cancer
|
Parecoxib Parecoxib 💬MicroRNAs in cancer
| Parecoxib | 046 [3] 46, 71, 271 💬68. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PTGS2 [1] PTGS2 💬MicroRNAs in cancer
|
Parecoxib sodium Parecoxib sodium 💬MicroRNAs in cancer
| Parecoxib | 046 [3] 46, 71, 271 💬68. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
P2RY12 [1] P2RY12 💬Neuroactive ligand signaling
|
Clopidogrel bisulfate Clopidogrel bisulfate 💬Neuroactive ligand signaling
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬71. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
P2RY12 [1] P2RY12 💬Neuroactive ligand signaling
|
Clopidogrel Clopidogrel 💬Neuroactive ligand signaling
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬71. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
P2RY12 [1] P2RY12 💬Neuroactive ligand signaling
|
Clopidogrel hydrochloride Clopidogrel hydrochloride 💬Neuroactive ligand signaling
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬71. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
P2RY12 [1] P2RY12 💬Neuroactive ligand signaling
|
Clopidogrel besilate Clopidogrel besilate 💬Neuroactive ligand signaling
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬71. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Dexamethasone Dexamethasone 💬Neuroactive ligand-receptor interaction
| Dexamethasone | 013 [29] 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬75. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Dexamethasone sodium phosphate Dexamethasone sodium phosphate 💬Neuroactive ligand-receptor interaction
| Dexamethasone | 013 [29] 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬75. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Dexamethasone phosphate Dexamethasone phosphate 💬Neuroactive ligand-receptor interaction
| Dexamethasone | 013 [29] 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬75. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTH1R [1] PTH1R 💬Neuroactive ligand-receptor interaction
|
Teriparatide acetate Teriparatide acetate 💬Neuroactive ligand-receptor interaction
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬78. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTH1R [1] PTH1R 💬Neuroactive ligand-receptor interaction
|
Teriparatide Teriparatide 💬Neuroactive ligand-receptor interaction
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬78. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTH1R [1] PTH1R 💬Neuroactive ligand-receptor interaction
|
Teriparatide acetate Teriparatide acetate 💬Neuroactive ligand-receptor interaction
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬78. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬NF-kappa B signaling pathway
|
Valdecoxib Valdecoxib 💬NF-kappa B signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬81. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬NF-kappa B signaling pathway
|
Parecoxib Parecoxib 💬NF-kappa B signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬81. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬NF-kappa B signaling pathway
|
Parecoxib sodium Parecoxib sodium 💬NF-kappa B signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬81. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
PTGS2 [1] PTGS2 💬Ovarian steroidogenesis
|
Valdecoxib Valdecoxib 💬Ovarian steroidogenesis
| Parecoxib | 046 [3] 46, 71, 271 💬84. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
PTGS2 [1] PTGS2 💬Ovarian steroidogenesis
|
Parecoxib Parecoxib 💬Ovarian steroidogenesis
| Parecoxib | 046 [3] 46, 71, 271 💬84. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
PTGS2 [1] PTGS2 💬Ovarian steroidogenesis
|
Parecoxib sodium Parecoxib sodium 💬Ovarian steroidogenesis
| Parecoxib | 046 [3] 46, 71, 271 💬84. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Oxidative phosphorylation 💬 2 genes, 7 drugs (DrugBank) and 29 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬Oxidative phosphorylation
| Lansoprazole | 063 [8] 63, 71, 85, 98, 166, 222, 223, 299 💬87. Oxidative phosphorylation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PTGS2 [1] PTGS2 💬Oxytocin signaling pathway
|
Valdecoxib Valdecoxib 💬Oxytocin signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬88. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PTGS2 [1] PTGS2 💬Oxytocin signaling pathway
|
Parecoxib Parecoxib 💬Oxytocin signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬88. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PTGS2 [1] PTGS2 💬Oxytocin signaling pathway
|
Parecoxib sodium Parecoxib sodium 💬Oxytocin signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬88. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Parathyroid hormone synthesis, secretion and action 💬 24 genes, 63 drugs (DrugBank) and 70 diseases |
PTH1R [1] PTH1R 💬Parathyroid hormone synthesis, secretion and action
|
Teriparatide acetate Teriparatide acetate 💬Parathyroid hormone synthesis, secretion and action
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬91. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Parathyroid hormone synthesis, secretion and action 💬 24 genes, 63 drugs (DrugBank) and 70 diseases |
PTH1R [1] PTH1R 💬Parathyroid hormone synthesis, secretion and action
|
Teriparatide Teriparatide 💬Parathyroid hormone synthesis, secretion and action
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬91. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Parathyroid hormone synthesis, secretion and action 💬 24 genes, 63 drugs (DrugBank) and 70 diseases |
PTH1R [1] PTH1R 💬Parathyroid hormone synthesis, secretion and action
|
Teriparatide acetate Teriparatide acetate 💬Parathyroid hormone synthesis, secretion and action
| Teriparatide | 046 [7] 46, 68, 70, 71, 172, 235, 274 💬91. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PTGS2 [1] PTGS2 💬Pathways in cancer
|
Valdecoxib Valdecoxib 💬Pathways in cancer
| Parecoxib | 046 [3] 46, 71, 271 💬94. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PTGS2 [1] PTGS2 💬Pathways in cancer
|
Parecoxib Parecoxib 💬Pathways in cancer
| Parecoxib | 046 [3] 46, 71, 271 💬94. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PTGS2 [1] PTGS2 💬Pathways in cancer
|
Parecoxib sodium Parecoxib sodium 💬Pathways in cancer
| Parecoxib | 046 [3] 46, 71, 271 💬94. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
PTGS2 [1] PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Valdecoxib Valdecoxib 💬Pathways of neurodegeneration - multiple diseases
| Parecoxib | 046 [3] 46, 71, 271 💬97. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
PTGS2 [1] PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Parecoxib Parecoxib 💬Pathways of neurodegeneration - multiple diseases
| Parecoxib | 046 [3] 46, 71, 271 💬97. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
PTGS2 [1] PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Parecoxib sodium Parecoxib sodium 💬Pathways of neurodegeneration - multiple diseases
| Parecoxib | 046 [3] 46, 71, 271 💬97. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
P2RY12 [1] P2RY12 💬Platelet activation
|
Clopidogrel bisulfate Clopidogrel bisulfate 💬Platelet activation
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬100. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
P2RY12 [1] P2RY12 💬Platelet activation
|
Clopidogrel Clopidogrel 💬Platelet activation
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬100. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
P2RY12 [1] P2RY12 💬Platelet activation
|
Clopidogrel hydrochloride Clopidogrel hydrochloride 💬Platelet activation
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬100. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
P2RY12 [1] P2RY12 💬Platelet activation
|
Clopidogrel besilate Clopidogrel besilate 💬Platelet activation
| Clopidogrel | 040 [7] 40, 49, 51, 62, 71, 86, 222 💬100. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PTGS2 [1] PTGS2 💬Regulation of lipolysis in adipocytes
|
Valdecoxib Valdecoxib 💬Regulation of lipolysis in adipocytes
| Parecoxib | 046 [3] 46, 71, 271 💬104. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PTGS2 [1] PTGS2 💬Regulation of lipolysis in adipocytes
|
Parecoxib Parecoxib 💬Regulation of lipolysis in adipocytes
| Parecoxib | 046 [3] 46, 71, 271 💬104. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PTGS2 [1] PTGS2 💬Regulation of lipolysis in adipocytes
|
Parecoxib sodium Parecoxib sodium 💬Regulation of lipolysis in adipocytes
| Parecoxib | 046 [3] 46, 71, 271 💬104. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
PTGS2 [1] PTGS2 💬Retrograde endocannabinoid signaling
|
Valdecoxib Valdecoxib 💬Retrograde endocannabinoid signaling
| Parecoxib | 046 [3] 46, 71, 271 💬107. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
PTGS2 [1] PTGS2 💬Retrograde endocannabinoid signaling
|
Parecoxib Parecoxib 💬Retrograde endocannabinoid signaling
| Parecoxib | 046 [3] 46, 71, 271 💬107. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
PTGS2 [1] PTGS2 💬Retrograde endocannabinoid signaling
|
Parecoxib sodium Parecoxib sodium 💬Retrograde endocannabinoid signaling
| Parecoxib | 046 [3] 46, 71, 271 💬107. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
PTGS2 [1] PTGS2 💬Serotonergic synapse
|
Valdecoxib Valdecoxib 💬Serotonergic synapse
| Parecoxib | 046 [3] 46, 71, 271 💬110. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
PTGS2 [1] PTGS2 💬Serotonergic synapse
|
Parecoxib Parecoxib 💬Serotonergic synapse
| Parecoxib | 046 [3] 46, 71, 271 💬110. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
PTGS2 [1] PTGS2 💬Serotonergic synapse
|
Parecoxib sodium Parecoxib sodium 💬Serotonergic synapse
| Parecoxib | 046 [3] 46, 71, 271 💬110. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PTGS2 [1] PTGS2 💬Small cell lung cancer
|
Valdecoxib Valdecoxib 💬Small cell lung cancer
| Parecoxib | 046 [3] 46, 71, 271 💬113. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PTGS2 [1] PTGS2 💬Small cell lung cancer
|
Parecoxib Parecoxib 💬Small cell lung cancer
| Parecoxib | 046 [3] 46, 71, 271 💬113. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PTGS2 [1] PTGS2 💬Small cell lung cancer
|
Parecoxib sodium Parecoxib sodium 💬Small cell lung cancer
| Parecoxib | 046 [3] 46, 71, 271 💬113. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
SCN2A [3] SCN2A, SCN3A, SCN9A 💬
|
Bupivacaine hydrochloride Bupivacaine hydrochloride 💬Taste transduction
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬116. Taste transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
SCN2A [3] SCN2A, SCN3A, SCN9A 💬
|
Bupivacaine Bupivacaine 💬Taste transduction
| Bupivacaine | 046 [10] 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬116. Taste transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
SCN2A [3] SCN2A, SCN3A, SCN9A 💬
|
Ropivacaine hydrochloride Ropivacaine hydrochloride 💬Taste transduction
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬118. Taste transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
SCN2A [3] SCN2A, SCN3A, SCN9A 💬
|
Ropivacaine Ropivacaine 💬Taste transduction
| Ropivacaine | 022 [7] 22, 36, 46, 63, 70, 71, 97 💬118. Taste transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pitavastatin calcium Pitavastatin calcium 💬Terpenoid backbone biosynthesis
| Pitavastatin | 049 [4] 49, 71, 79, 90 💬120. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pitavastatin magnesium Pitavastatin magnesium 💬Terpenoid backbone biosynthesis
| Pitavastatin | 049 [4] 49, 71, 79, 90 💬120. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PTGS2 [1] PTGS2 💬TNF signaling pathway
|
Valdecoxib Valdecoxib 💬TNF signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬122. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PTGS2 [1] PTGS2 💬TNF signaling pathway
|
Parecoxib Parecoxib 💬TNF signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬122. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PTGS2 [1] PTGS2 💬TNF signaling pathway
|
Parecoxib sodium Parecoxib sodium 💬TNF signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬122. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PTGS2 [1] PTGS2 💬VEGF signaling pathway
|
Valdecoxib Valdecoxib 💬VEGF signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬125. VEGF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PTGS2 [1] PTGS2 💬VEGF signaling pathway
|
Parecoxib Parecoxib 💬VEGF signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬125. VEGF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PTGS2 [1] PTGS2 💬VEGF signaling pathway
|
Parecoxib sodium Parecoxib sodium 💬VEGF signaling pathway
| Parecoxib | 046 [3] 46, 71, 271 💬125. VEGF signaling pathway
|
Adrenergic signaling in cardiomyocytes
31 genes, 86 drugs (DrugBank) and 81 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Arachidonic acid metabolism
5 genes, 29 drugs (DrugBank) and 46 diseases
Bile secretion
13 genes, 36 drugs (DrugBank) and 66 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
Cadherin signaling
41 genes, 70 drugs (DrugBank) and 81 diseases
Chemical carcinogenesis - DNA adducts
1 gene, 26 drugs (DrugBank) and 43 diseases
Collecting duct acid secretion
3 genes, 10 drugs (DrugBank) and 36 diseases
Complement and coagulation cascades
21 genes, 46 drugs (DrugBank) and 60 diseases
Dopaminergic synapse
33 genes, 105 drugs (DrugBank) and 105 diseases
Efferocytosis
30 genes, 78 drugs (DrugBank) and 97 diseases
Endocrine and other factor-regulated calcium reabsorption
9 genes, 31 drugs (DrugBank) and 50 diseases
Gastric acid secretion
14 genes, 54 drugs (DrugBank) and 63 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
IL-17 signaling pathway
20 genes, 65 drugs (DrugBank) and 91 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leishmaniasis
40 genes, 76 drugs (DrugBank) and 105 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
NF-kappa B signaling pathway
23 genes, 81 drugs (DrugBank) and 97 diseases
Ovarian steroidogenesis
7 genes, 40 drugs (DrugBank) and 53 diseases
Oxidative phosphorylation
2 genes, 7 drugs (DrugBank) and 29 diseases
Oxytocin signaling pathway
34 genes, 85 drugs (DrugBank) and 112 diseases
Parathyroid hormone synthesis, secretion and action
24 genes, 63 drugs (DrugBank) and 70 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Retrograde endocannabinoid signaling
34 genes, 70 drugs (DrugBank) and 74 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Taste transduction
29 genes, 93 drugs (DrugBank) and 78 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 62 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
